EDGAR Filing Documents for 0001654954-18-011417

Form 8-K - Current report:

SEC Accession No. 0001654954-18-011417

Filing Date

2018-10-22

Accepted

2018-10-19 21:31:09

Documents

Period of Report

2018-10-22

Items

Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	mbvx8k_oct222018.htm	8-K	31006
2	PRESENTATION	ex99-1.htm	EX-99.1	17427
3	IMAGE	ex99-1000.jpg	GRAPHIC	29060
4	IMAGE	ex99-1001.jpg	GRAPHIC	70488
5	IMAGE	ex99-1002.jpg	GRAPHIC	45584
6	IMAGE	ex99-1003.jpg	GRAPHIC	55313
7	IMAGE	ex99-1004.jpg	GRAPHIC	53643
8	IMAGE	ex99-1005.jpg	GRAPHIC	50776
9	IMAGE	ex99-1006.jpg	GRAPHIC	52291
10	IMAGE	ex99-1007.jpg	GRAPHIC	50765
11	IMAGE	ex99-1008.jpg	GRAPHIC	60276
12	IMAGE	ex99-1009.jpg	GRAPHIC	59244
13	IMAGE	ex99-1010.jpg	GRAPHIC	55700
14	IMAGE	ex99-1011.jpg	GRAPHIC	47472
15	IMAGE	ex99-1012.jpg	GRAPHIC	45257
16	IMAGE	ex99-1013.jpg	GRAPHIC	51270
17	IMAGE	ex99-1014.jpg	GRAPHIC	51642
18	IMAGE	ex99-1015.jpg	GRAPHIC	45760
19	IMAGE	ex99-1016.jpg	GRAPHIC	36750
20	IMAGE	ex99-1017.jpg	GRAPHIC	55137
21	IMAGE	ex99-1018.jpg	GRAPHIC	21723
	Complete submission text file	0001654954-18-011417.txt		1343659

Mailing Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121

Business Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121 8582599405

MABVAX THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001109196 (see all company filings)